Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Engineering regenerative macrophages to support cardiomyocyte survival in cardiac cell therapy

EF 2025-26

Résumé
Since heart cells do not regenerate, heart injuries are hard to treat. Transplanting heart cells into the injured heart has shown promise, but these cells die quickly after transplantation. Macrophages, which are immune cells that ingest dead cells, have been shown to support heart cell survival and could improve transplantation therapy. Our lab showed that macrophages improve the function of lab-grown heart microtissues by cleaning up dead cells. After ingesting dead cells, macrophages become beneficially reprogrammed to promote microtissue survival and function. However, the specific type of dead cell cargo that reprogram macrophages in the heart is unknown. Studies show that when macrophages ingest cells that have undergone programmed cell death (apoptosis), they behave differently to when they ingest cells that have undergone premature death (necrosis). Understanding how different cargo in heart tissue impacts macrophage reprogramming would allow us to identify macrophage receptors that detect beneficial cargo. Then, we could genetically add more of these receptors to macrophages to accelerate their reprogramming. In this project, we will mix macrophages with cargo from different types of dead cells and measure the effect on macrophage reprogramming. We expect that apoptotic cargo will cause beneficial macrophage reprogramming, while necrotic cargo will inhibit it. Next, we will identify the macrophage receptors that detect each type of cargo. We will genetically remove or boost these receptors in macrophages and evaluate the changes in macrophage reprogramming. Ultimately, we will make macrophages express more beneficial cargo receptors and fewer harmful cargo receptors. These macrophages could be used to support heart cell survival in transplantation therapy.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573032
Name
Mitchell Aniela J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Engineering regenerative macrophages to support cardiomyocyte survival in cardiac cell therapy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cardiac Injury; Cardiomyocyte; Cell Death; Cell Therapy; Efferocytosis; Fibroblast; Genetic Engineering; Macrophage; Stem Cell; Tissue Regeneration
Abstract
Since heart cells do not regenerate, heart injuries are hard to treat. Transplanting heart cells into the injured heart has shown promise, but these cells die quickly after transplantation. Macrophages, which are immune cells that ingest dead cells, have been shown to support heart cell survival and could improve transplantation therapy. Our lab showed that macrophages improve the function of lab-grown heart microtissues by cleaning up dead cells. After ingesting dead cells, macrophages become beneficially reprogrammed to promote microtissue survival and function. However, the specific type of dead cell cargo that reprogram macrophages in the heart is unknown. Studies show that when macrophages ingest cells that have undergone programmed cell death (apoptosis), they behave differently to when they ingest cells that have undergone premature death (necrosis). Understanding how different cargo in heart tissue impacts macrophage reprogramming would allow us to identify macrophage receptors that detect beneficial cargo. Then, we could genetically add more of these receptors to macrophages to accelerate their reprogramming. In this project, we will mix macrophages with cargo from different types of dead cells and measure the effect on macrophage reprogramming. We expect that apoptotic cargo will cause beneficial macrophage reprogramming, while necrotic cargo will inhibit it. Next, we will identify the macrophage receptors that detect each type of cargo. We will genetically remove or boost these receptors in macrophages and evaluate the changes in macrophage reprogramming. Ultimately, we will make macrophages express more beneficial cargo receptors and fewer harmful cargo receptors. These macrophages could be used to support heart cell survival in transplantation therapy.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mitchell, Aniela J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~